Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Accounts Payables (2021 - 2025)

Bioregenx's Accounts Payables history spans 5 years, with the latest figure at $615990.0 for Q4 2025.

  • Quarterly results put Accounts Payables at $615990.0 for Q4 2025, up 44.1% from a year ago — trailing twelve months through Dec 2025 was $615990.0 (up 44.1% YoY), and the annual figure for FY2025 was $615990.0, up 44.1%.
  • Accounts Payables for Q4 2025 was $615990.0 at Bioregenx, up from $459652.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $615990.0 in Q4 2025 to a low of $11996.0 in Q4 2021.
  • The 5-year median for Accounts Payables is $306276.0 (2023), against an average of $270444.8.
  • The sharpest move saw Accounts Payables skyrocketed 1784.61% in 2024, then plummeted 80.57% in 2025.
  • Year by year, Accounts Payables stood at $11996.0 in 2021, then surged by 64.4% to $19721.0 in 2022, then surged by 1125.57% to $241695.0 in 2023, then surged by 76.87% to $427478.0 in 2024, then surged by 44.1% to $615990.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $615990.0, $459652.0, and $568799.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.